Latest news about R-Biopharm AG:

www.presseportal.de/st/R-Biopharm

Management

2017-10_christian-dreher-02_rgb_lowres_quer
Christian Dreher - CEO
Download image
Foto Firmengebäude
Headquarter R-Biopharm AG
Download image

Current topics

Corona rapid testing center Darmstadt

Corona-Schnelltest-Zentrum DA
The corona rapid testing center Darmstadt in Pfungstadt which uses the rapid test RIDA®QUICK SARS-CoV-2 Antigen by R-Biopharm.
Download image
Corona-Schnelltest-Zentrum DA
A staff member of the corona rapid testing center Darmstadt scans the registration code from a customer´s mobile phone.
Download image
Corona-Schnelltest-Zentrum DA
A staff member of the corona rapid testing center Darmstadt scans the printed registration code.
Download image
Corona-Schnelltest-Zentrum DA
Drive through: A staff member of the corona rapid testing center Darmstadt collects the throat swap through the open car window.
Download image
Corona-Schnelltest-Zentrum DA
The swab is safely locked for transportation from the corona rapid testing center Darmstadt to humatrix AG which analyzes the samples in its laboratory.
Download image
Corona-Schnelltest-Zentrum DA
Dr. Anna Carina Eichhorn, director of humatrix AG, visits the corona rapid testing center Darmstadt with Christian Dreher, CEO of R-Biopharm AG.
Download image
R-Biopharm / humatrix
Rapid test RIDA®QUICK SARS-CoV-2 Antigen by R-Biopharm provides within 20 minutes information whether an infection with the corona virus is present.
Download image
R-Biopharm / humatrix
Preparation of reagents for the corona rapid test RIDA®QUICK SARS-CoV-2 Antigen by R-Biopharm.
Download image
R-Biopharm / humatrix
Rapid test RIDA®QUICK SARS-CoV-2 Antigen by R-Biopharm provides information whether an infection with the corona virus is present within 20 minutes.
Download image
R-Biopharm / humatrix
Within 20 minutes the test strips of the rapid test RIDA®QUICK SARS-CoV-2 Antigen by R-Biopharm indicate if an infection with the corona virus is present.
Download image
R-Biopharm / humatrix
Preparation of test tubes for the corona rapid test RIDA®QUICK SARS-CoV-2 Antigen by R-Biopharm.
Download image
R-Biopharm / humatrix
Dr. Anna Carina Eichhorn, director of humatrix AG, with the corona rapid test RIDA®QUICK SARS-CoV-2 Antigen by R-Biopharm which is used to examine the samples of the rapid test center in Pfungstadt.
Download image
R-Biopharm / humatrix
Dr. Anna Carina Eichhorn, director of humatrix AG, Pfungstadt
Download image
SARS-CoV-2 negativ: In 20 Minuten zum verlässlichen Ergebnis
SARS-CoV-2 negative: The antigen rapid tests by R-Biopharm deliver reliable results in 20 minutes.
Download image
SARS-CoV-2 Antigen-Schnelltest der R-Biopharm AG bringt schnelle Sicherheit für Gesundheitsämter, Seniorenheime und Arztpraxen
The antigen rapid tests by R-Biopharm deliver reliable results in 20 minutes.
Download image

Impressions from the lab

Die R-Biopharm AG mit Hauptsitz in Darmstadt bringt als eines der ersten Diagnostikunternehmen weltweit einen sogenannten real-time RT-PCR Test zur Erkennung des SARS-CoV-2 Virus auf den Markt.
R-Biopharm AG based in Darmstadt is the first diagnostics company worldwide to launch a real-time RT-PCR test for the detection of the SARS-CoV-2 virus.
Download image
Die Krise als produktiver Zustand: R-Biopharm ist es bisher gelungen, die Produktion ohne Einschränkung aufrechtzuerhalten und die Versorgung der Kunden zu gewährleisten.
Crisis as a productive state: R-Biopharm so far has been capable of maintaining production without any limitation, ensuring uninterrupted supply of its customers.
Download image
Das RIDA®GENE SARS-CoV-2 RUO Testkit wurde bei R-Biopharm im Geschäftsbereich Klinische Diagnostik und am Standort Berlin-Buch entwickelt. Zum Kerngeschäft der klinischen Diagnostik gehört das Entwickeln, Herstellen und Vermarkten von Systemlösungen zum Nachweis von Krankheitserregern in humanen Proben.
The CE certified RT-PCR test kit RIDA®GENE SARS-CoV-2 was developed by the R-Biopharm division Clinical Diagnostics at the Berlin-Buch site.
Download image
Mit dem Testverfahren können bis zu 96 Proben gleichzeitig in weniger als zwei Stunden analysiert werden. Pro Patient wird nur eine Probenanalyse benötigt.
The SARS-CoV-2 test procedure by R-Biopharm allows to analyze up to 96 samples simultaneously in less than two hours.
Download image
Mit Spirit und Faszination für die Gesundheit des Menschen: Von der Entscheidung bis zum ersten verfügbaren Testkit benötigte R-Biopharm vier Wochen.
With inspiration and fascination for human health: From decision to the first available test kit R-Biopharm needed four weeks.
Download image

Copyright: Thomas Lohnes / R-Biopharm AG

Minister for Social Affairs and Integration

mg_0956
The Hessian Minister for Social Affairs and Integration Kai Klose (right) visits R-Biopharm for the presentation of the antigen rapid test in context of the study “Safe School Hessen“. Here talking to CEO Christian Dreher.
Download image
mg_0906
The Hessian Minister for Social Affairs and Integration Kai Klose (right) and the virologist from Frankfurt Sandra Ciesek visit R-Biopharm for a presentation of the antigen rapid test.
Download image
mg_0860
The Hessian Minister for Social Affairs and Integration Kai Klose (right) and the virologist from Frankfurt Sandra Ciesek listen to an explanation of the antigen rapid test during their visit at R-Biopharm.
Download image
mg_0798
The Hessian Minister for Social Affairs and Integration Kai Klose (left) and the virologist Sandra Ciesek during a tour through R-Biopharm guided by CEO Christian Dreher (right)
Download image
mg_0960
Virologist Sandra Ciesek talks to the media during her visit at R-Biopharm.
Download image
mg_0933
The Hessian Minister for Social Affairs and Integration Kai Klose talks to the media during his visit at R-Biopharm.
Download image

Copyright: Matthias Wenger